Who is sponsoring NCT03474939?

NCT03474939 is sponsored by Medical University of Warsaw.

What drugs are being tested in NCT03474939?

Interventions in NCT03474939: Midazolam Oral Tablet, Placebo Oral Tablet.

What condition does NCT03474939 study?

NCT03474939 studies Preanesthetic Medication, Copeptin.

Is NCT03474939 still recruiting?

NCT03474939 is currently completed. Last updated 19 April 2019.

Last reviewed 2019-04-19 · How we verify

NCT03474939

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Midazolam Premedication on Copeptine Concentration in Blood

Completed Phase 4 Last updated 19 April 2019

What this trial tests

Phase 4 trial testing Midazolam Oral Tablet in Preanesthetic Medication in 40 participants. Completed in 1 March 2019.

Timeline

3 April 2017

Primary endpoint
1 March 2019

1 March 2019

Quick facts

Lead sponsor	Medical University of Warsaw
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	40
Start date	3 April 2017
Primary completion	1 March 2019
Estimated completion	1 March 2019
Sites	1 location across Poland

Drugs / interventions tested

Midazolam Oral Tablet
Placebo Oral Tablet — full drug profile →

Conditions studied

Preanesthetic Medication — all drugs for Preanesthetic Medication →
Copeptin — all drugs for Copeptin →

Sponsor

Medical University of Warsaw

Who can join

18 and older, any sex, with Preanesthetic Medication or Copeptin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aim is to assess whether premedication with midazolam prior to surgery affects copeptin concentration in blood.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03474939 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 19 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03474939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing